Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Cannabis Legalization topic
No spam. Unsubscribe anytime.
House Health Committee advances bill to legalize and regulate adult-use cannabis, 14-12
Summary
The Pennsylvania House Health Committee voted 14-12 to report House Bill 1,200, a 173‑page measure to legalize and regulate adult-use cannabis, advancing a plan that would create state-run retail sales, a new licensing system, equity provisions and taxes dedicated to treatment and community reinvestment.
Get email alerts on the Cannabis Legalization topic
No spam. Unsubscribe anytime.
The House Health Committee on Friday voted 14-12 to report House Bill 1,200, sending a 173‑page plan to legalize and regulate adult-use cannabis in Pennsylvania to the full House.
The committee vote advances a bill that would allow adults 21 and older to possess defined personal amounts of cannabis, apply for a home‑cultivation permit (two mature and two immature plants per household), and buy products through a new state-regulated system. The bill would expand the state Liquor Control Board with two members (one with cannabis expertise and one with public‑health expertise), authorize publicly owned retail stores as the primary retail channel, create six license categories (microcultivator, cultivator, microprocessor, processor, transporter and on‑site consumption), and establish an Office of Social and Economic Equity to oversee outreach, loans and grants for equity applicants.
Why it matters: committee members on both sides framed the bill as a public‑health and social‑equity intervention aimed at moving an unregulated market into a regulated system while creating revenue for treatment and community reinvestment. Opponents said the bill was rushed through without sufficient review, raising concerns about process, enforcement and public‑health impacts on children and pregnant people.
Sponsor Representative Krajewski, the bill's prime sponsor, told the committee the measure "creates a balanced, responsible, and robust framework to legalize and regulate adult use cannabis" after six committee hearings and meetings with stakeholders. He said the hybrid model of publicly owned retail and small‑scale private licenses would protect public health while directing revenue to communities harmed by past criminalization.
Members who opposed the bill criticized the timing and process. Representative Krupa said the bill was "rammed through the committee and the legislature" with little time for review; Representative Rapp, who spoke against the measure, said she was "disappointed by the procedural handling" and argued the measure would worsen substance‑use problems and undermine maternal and child health.
Key provisions summarized at the hearing by staffer Dylan include: the legal definition of cannabis tied to THC thresholds; a private‑consumption rule that limits public use to private residences and allows consumption in up to 20 percent of rooms in lodging establishments that opt in; a prohibition on public marketing and products appealing to children; testing and lab oversight mirroring the medical program; and licensing awarded by a mix of merit (for cultivator and processor) and a vetted lottery for other categories. The bill requires signed labor peace agreements for license issuance and renewals and reserves two licenses per type for worker cooperatives.
Taxes and spending: the bill would impose a 12 percent tax on cannabis seed, flower and products sold at cannabis stores and a 6 percent tax on paraphernalia; municipalities that opt in for on‑site consumption could levy an additional 3 percent local tax for those sales. All fees and taxes would go into a Cannabis Revenue Fund to support implementation (LCB, revenue, state police, attorney general and the Office of Social and Economic Equity). After operations, remaining funds would be distributed: 50 percent to a communities reimagined and reinvestment restricted account; 10 percent to a substance use disorder prevention and treatment account; 5 percent to a cannabis development fund; 2.5 percent to the minority business development authority; 2 percent to AOPC for grants; remainder to the general fund.
Enforcement and protections: the bill would expunge certain past cannabis convictions where no mandatory minimums or enhancements applied and would prohibit discrimination based solely on legal cannabis use in employment, custody, child welfare, probation or parole; employers would retain the ability to prevent impairment at work and take action against employees who are impaired on the job. Child welfare decisions would continue to be evaluated based on impairment and ability to care for a child rather than solely on past use, committee staff said.
Committee debate focused as much on process as on policy. Several Republicans and some Democrats urged additional hearings and time for stakeholders — including district attorneys, state police and medical organizations — to review the 173 pages that were posted the night before committee consideration. A motion to table the bill for further study was offered and seconded; that motion failed on a roll call (the table motion did not carry). The committee then voted 14-12 to report the bill as committed.
What's next: House Bill 1,200 will be scheduled for floor consideration. The bill would still need to pass both chambers and survive negotiation with the governor's office, and several committee members said they expect more amendments and debate on the House floor and in the Senate.
Ending: supporters said the proposal would bring oversight, testing and revenue to a widely available but unregulated market; opponents said the bill raises unresolved enforcement and public‑health questions and criticized the speed of the committee process. The committee record shows the measure advancing, but significant policy and procedural debate remains ahead.

